Literature DB >> 29934876

Long-term follow-up of female prolactinoma patients at child-bearing age after transsphenoidal surgery.

Na Yi1, Lijin Ji1, Qi Zhang1, Shuo Zhang1, Xiaoxia Liu1, Xuefei Shou2, Bin Lu3.   

Abstract

CONTEXT: Prolactinoma is the most common subtype of functional pituitary adenoma. Effective therapy is required for women of child-bearing age to achieve remission at serum prolactin level and regain reproductive function.
PURPOSE: To evaluate long-term outcomes, including menstrual recovery, after transsphenoidal surgery on female prolactinoma patients by experienced neurosurgeons.
DESIGN: Observational study. PATIENTS: Consecutive female prolactinoma patients aged from 16 to 45 years were included. Histological analysis after surgery revealed adenoma with positive staining for prolactin. Plurihormonal cell adenomas were excluded. MAIN MEASUREMENTS: Clinical manifestations, surgical indications, serum prolactin level before and after surgery, surgical complications, pituitary fuctions, drug maintenance, the status of menstruation, and pregnancy.
RESULTS: Sixty-three consecutive female patients with a mean age of 29.5 ± 1.1 years were included. Based on magnetic resonance imaging findings before surgery, 31 (49.2%) patients had microadenoma, and the remaining 32 (50.8%) had macroadenoma. The median follow-up after transsphenoidal surgery was 53 (33-74) months, and long-term surgical remission was achieved in 50 (79.37%) patients with 28 (90.32%) microadenomas and 22 (68.75%) macroadenomas. No meningitis or persistent cerebrospinal fluid leaks occurred. Only one case suffered from persistent diabetes insipidus at follow-up. No severe pituitary dysfunction was observed in microprolactinoma patients. Of patients with menstrual disorders, 85% regained regular menstrual cycles after surgery. Nineteen patients in this cohort desired pregnancy and 15 of them successfully gave birth after surgery. All 17 microadenoma patients with modern surgical indications achieved normal prolactin levels and regular menstrual cycles with only one patient on drug therapy at follow-up.
CONCLUSION: Long-term follow-up showed a high remission rate in female prolactinoma patients, especially in microadenoma patients, after surgery. Transsphenoidal surgery performed by experienced neurosurgeons may offer a valuable approach to treat female microprolactinoma patients of child-bearing age with modern indications for surgery.

Entities:  

Keywords:  Experienced neurosurgeon; Fertility; Menstrual cycle; Prolactinoma; Transsphenoidal surgery; Women

Mesh:

Year:  2018        PMID: 29934876     DOI: 10.1007/s12020-018-1652-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  28 in total

Review 1.  Diagnosis and management of prolactinomas and non-functioning pituitary adenomas.

Authors:  Angela Rogers; Niki Karavitaki; John A H Wass
Journal:  BMJ       Date:  2014-09-10

Review 2.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

3.  Medically treated prolactin-secreting pituitary adenomas: when should we operate?

Authors:  Fernando L Vale; Armen R Deukmedjian; Shan Hann; Vitra Shah; Anthony D Morrison
Journal:  Br J Neurosurg       Date:  2012-08-31       Impact factor: 1.596

4.  Transsphenoidal microsurgical results of female patients with prolactinomas.

Authors:  Hidetoshi Ikeda; Kazuo Watanabe; Teiji Tominaga; Takashi Yoshimoto
Journal:  Clin Neurol Neurosurg       Date:  2013-03-13       Impact factor: 1.876

5.  Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients.

Authors:  J Kreutzer; R Buslei; H Wallaschofski; B Hofmann; C Nimsky; R Fahlbusch; M Buchfelder
Journal:  Eur J Endocrinol       Date:  2008-01       Impact factor: 6.664

6.  Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series.

Authors:  Amir R Dehdashti; Ahmed Ganna; Konstantina Karabatsou; Fred Gentili
Journal:  Neurosurgery       Date:  2008-05       Impact factor: 4.654

Review 7.  Treating prolactinomas with dopamine agonists: always worth the gamble?

Authors:  Sean Noronha; Victoria Stokes; Niki Karavitaki; Ashley Grossman
Journal:  Endocrine       Date:  2015-09-04       Impact factor: 3.633

8.  Effect of transsphenoidal surgery and standard care on fertility related indicators of patients with prolactinomas during child-bearing period.

Authors:  Zhiyue Yan; Yiming Wang; Xuefei Shou; Jianguang Su; Liwei Lang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

9.  Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery.

Authors:  Arun P Amar; William T Couldwell; Joseph C T Chen; Martin H Weiss
Journal:  J Neurosurg       Date:  2002-08       Impact factor: 5.115

Review 10.  Diagnosis and Treatment of Pituitary Adenomas: A Review.

Authors:  Mark E Molitch
Journal:  JAMA       Date:  2017-02-07       Impact factor: 56.272

View more
  5 in total

1.  Extra-Pseudocapsular Transsphenoidal Surgery for Microprolactinoma in Women.

Authors:  Juan Chen; Xiang Guo; Zhuangzhuang Miao; Zhuo Zhang; Shengwen Liu; Xueyan Wan; Kai Shu; Yan Yang; Ting Lei
Journal:  J Clin Med       Date:  2022-07-05       Impact factor: 4.964

2.  Application of Contrast-Enhanced 3-Dimensional T2-Weighted Volume Isotropic Turbo Spin Echo Acquisition Sequence in the Diagnosis of Prolactin-Secreting Pituitary Microadenomas.

Authors:  Rui Guo; Yue Wu; Guangcheng Guo; Haiyang Zhou; Shoutang Liu; Zhenwei Yao; Yunping Xiao
Journal:  J Comput Assist Tomogr       Date:  2022 Jan-Feb 01       Impact factor: 1.826

Review 3.  Surgery and Medical Treatment in Microprolactinoma: A Systematic Review and Meta-Analysis.

Authors:  Jianglong Lu; Lin Cai; Zerui Wu; Weiwei Lin; Jiadong Xu; Zhangzhang Zhu; Chengde Wang; Qun Li; Zhipeng Su
Journal:  Int J Endocrinol       Date:  2021-08-30       Impact factor: 3.257

4.  Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis.

Authors:  Xiangming Cai; Junhao Zhu; Jin Yang; Chao Tang; Zixiang Cong; Chiyuan Ma
Journal:  Chin Neurosurg J       Date:  2022-04-08

5.  Management of prolactinoma: a survey of endocrinologists in China.

Authors:  Lijin Ji; Na Yi; Qi Zhang; Shuo Zhang; Xiaoxia Liu; Hongli Shi; Bin Lu
Journal:  Endocr Connect       Date:  2018-10-01       Impact factor: 3.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.